Captrust Financial Advisors Sells 254 Shares of Veralto Co. (NYSE:VLTO)

Captrust Financial Advisors lessened its stake in Veralto Co. (NYSE:VLTO) by 0.8% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 32,944 shares of the company’s stock after selling 254 shares during the period. Captrust Financial Advisors’ holdings in Veralto were worth $3,355,000 at the end of the most recent reporting period.

Other institutional investors have also recently made changes to their positions in the company. Barclays PLC increased its stake in Veralto by 43.8% in the third quarter. Barclays PLC now owns 729,081 shares of the company’s stock valued at $81,556,000 after acquiring an additional 222,076 shares during the last quarter. Principal Financial Group Inc. increased its position in shares of Veralto by 207.2% during the 3rd quarter. Principal Financial Group Inc. now owns 1,122,898 shares of the company’s stock valued at $125,608,000 after purchasing an additional 757,389 shares during the last quarter. JPMorgan Chase & Co. raised its holdings in shares of Veralto by 14.7% during the 3rd quarter. JPMorgan Chase & Co. now owns 2,448,648 shares of the company’s stock valued at $273,906,000 after buying an additional 314,412 shares in the last quarter. First Hawaiian Bank lifted its position in Veralto by 49.6% in the 4th quarter. First Hawaiian Bank now owns 3,883 shares of the company’s stock worth $395,000 after buying an additional 1,287 shares during the last quarter. Finally, Wealth Enhancement Advisory Services LLC boosted its stake in Veralto by 0.3% in the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 70,415 shares of the company’s stock worth $7,877,000 after buying an additional 218 shares in the last quarter. Institutional investors own 91.28% of the company’s stock.

Insider Buying and Selling

In other news, SVP Surekha Trivedi sold 590 shares of the business’s stock in a transaction that occurred on Tuesday, February 25th. The stock was sold at an average price of $100.35, for a total value of $59,206.50. Following the sale, the senior vice president now directly owns 8,470 shares of the company’s stock, valued at $849,964.50. The trade was a 6.51 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CEO Jennifer Honeycutt sold 10,414 shares of the firm’s stock in a transaction that occurred on Tuesday, February 25th. The shares were sold at an average price of $100.35, for a total value of $1,045,044.90. Following the transaction, the chief executive officer now directly owns 104,496 shares of the company’s stock, valued at approximately $10,486,173.60. This trade represents a 9.06 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 64,578 shares of company stock valued at $6,192,048 over the last ninety days. Company insiders own 0.36% of the company’s stock.

Analyst Ratings Changes

VLTO has been the topic of several research reports. Royal Bank of Canada lifted their price target on shares of Veralto from $103.00 to $104.00 and gave the stock a “sector perform” rating in a research note on Thursday, May 1st. Robert W. Baird lifted their target price on shares of Veralto from $105.00 to $106.00 and gave the stock a “neutral” rating in a research report on Thursday, May 1st. Northcoast Research started coverage on shares of Veralto in a research report on Tuesday, May 6th. They set a “buy” rating and a $110.00 price target for the company. Citigroup lowered their target price on Veralto from $116.00 to $100.00 and set a “neutral” rating for the company in a research note on Monday, April 14th. Finally, Stifel Nicolaus raised their price target on Veralto from $102.00 to $104.00 and gave the stock a “buy” rating in a research report on Thursday, May 1st. Six investment analysts have rated the stock with a hold rating and five have given a buy rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus price target of $110.09.

Veralto Stock Performance

NYSE:VLTO opened at $97.07 on Friday. The company has a quick ratio of 1.69, a current ratio of 1.92 and a debt-to-equity ratio of 1.27. The firm’s fifty day simple moving average is $94.22 and its 200 day simple moving average is $99.78. The stock has a market cap of $24.06 billion, a P/E ratio of 29.06, a price-to-earnings-growth ratio of 4.24 and a beta of 0.99. Veralto Co. has a twelve month low of $83.87 and a twelve month high of $115.00.

Veralto (NYSE:VLTO) last announced its quarterly earnings results on Tuesday, April 29th. The company reported $0.95 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.87 by $0.08. Veralto had a net margin of 16.04% and a return on equity of 49.29%. The company had revenue of $1.33 billion for the quarter, compared to analysts’ expectations of $1.28 billion. During the same quarter in the previous year, the company earned $0.84 earnings per share. Veralto’s quarterly revenue was up 6.9% on a year-over-year basis. As a group, research analysts predict that Veralto Co. will post 3.66 EPS for the current year.

Veralto Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Wednesday, April 30th. Investors of record on Monday, March 31st were given a dividend of $0.11 per share. The ex-dividend date was Monday, March 31st. This represents a $0.44 annualized dividend and a dividend yield of 0.45%. Veralto’s dividend payout ratio is presently 12.57%.

About Veralto

Veralto Corporation provides water analytics, water treatment, marking and coding, and packaging and color services worldwide. It operates through two segments, Water Quality (WQ) and Product Quality & Innovation (PQI). The WQ segment offers precision instrumentation and water treatment technologies to measure, analyze, and treat water in residential, commercial, municipal, industrial, research, and natural resource applications through the Hach, Trojan Technologies, and ChemTreat brands.